Dear Valued Client,
In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in mind that we announce the creation of the 13910: Nitazene Analog Panel. Beginning with orders placed on or after June 27th, 2022, the 13910: Nitazene Analog Panel will include the following compounds:
- Butonitazene
- Etodesnitazene
- Etonitazene
- Flunitazene
- Isotodesnitazene
- Isotonitazene
- Metodesnitazene
- Metonitazene
- N-Pyrrolidino Etonitazene
- Protonitazene
In addition, as part of this change, these compounds will be removed from the 13710: Novel Emerging Compounds Panel. All of these compounds will still be included as part of the 70510: Comprehensive Panel, Blood with Analyte Assurance™.
You can always find the most recent publication for our panel offerings on our Test Catalog, found at www.axisfortox.com.
For specific questions regarding our tests or tests not found on our Test Catalog, please contact our Lab Client Support Team at [email protected]
We look forward to serving you.
Sincerely,
Matt Zollman
Director of Operations & Product Management